Scholarlink

Background <p>Benign prostatic hyperplasia (BPH) involves the enlargement of epithelial and stromal cells of the prostate gland. Its prevalence is increasing owing in part to the rising rate of metabolic syndrome, which includes dyslipidemia, hypertension, hyperinsulinemia, and central obesity. Despite this trend, there is a paucity of data on BPH and metabolic syndrome in the Ethiopian population. This study aims to assess the prevalence and factors associated with metabolic syndrome among BPH patients in southwestern Ethiopia.</p> Materials and methods <p>A hospital-based cross-sectional study was conducted with 158 BPH patients at Jimma University Medical Center (JUMC) from January 15 to April 15, 2024. Socio-demographic data were collected via a WHO stepwise questionnaire and trained nurses collected 5&#xa0;ml fasting blood samples. The samples were consequently analyzed by trained laboratory technologists at JUMC.</p> Results <p>The overall prevalence of metabolic syndrome among BPH patients was 38.6% (95% CI: 0.31,0.46). There were significant associations between factors such as age (AOR = 3.43, CI: 1.3, 9), residence (AOR = 3.35, CI:1.35,8.30), total cholesterol (AOR = 3.2, CI: 1.27,8.06), low LDL levels (AOR = 3.54, CI:1.08, 11.5 hyperuricemia (AOR = 3.21, CI:1.02,10.01), BMI (AOR = 3.47, CI:1.44,8.32), waist-to-hip ratio (WHR) (AOR = 5.07, CI:2.15,11.98), and metabolic syndrome.</p> Conclusion <p>The prevalence of metabolic syndrome among patients with BPH is notably high. The authors recommend the need for early assessment of risk factors and timely intervention to prevent potential complications.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Metabolic syndrome and associated factors among benign prostatic hyperplasia patients at Jimma University Medical center, Jimma, Southwest Ethiopia

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月11日

查看全文
  • Hundesa Emana Urgesa,
  • Zerihun Assefa Tereffe,
  • Tesfaye Adugna Leta,
  • Bedasa Addisu Nasi,
  • Segni Gemechu Hurisa

摘要

Background

Benign prostatic hyperplasia (BPH) involves the enlargement of epithelial and stromal cells of the prostate gland. Its prevalence is increasing owing in part to the rising rate of metabolic syndrome, which includes dyslipidemia, hypertension, hyperinsulinemia, and central obesity. Despite this trend, there is a paucity of data on BPH and metabolic syndrome in the Ethiopian population. This study aims to assess the prevalence and factors associated with metabolic syndrome among BPH patients in southwestern Ethiopia.

Materials and methods

A hospital-based cross-sectional study was conducted with 158 BPH patients at Jimma University Medical Center (JUMC) from January 15 to April 15, 2024. Socio-demographic data were collected via a WHO stepwise questionnaire and trained nurses collected 5 ml fasting blood samples. The samples were consequently analyzed by trained laboratory technologists at JUMC.

Results

The overall prevalence of metabolic syndrome among BPH patients was 38.6% (95% CI: 0.31,0.46). There were significant associations between factors such as age (AOR = 3.43, CI: 1.3, 9), residence (AOR = 3.35, CI:1.35,8.30), total cholesterol (AOR = 3.2, CI: 1.27,8.06), low LDL levels (AOR = 3.54, CI:1.08, 11.5 hyperuricemia (AOR = 3.21, CI:1.02,10.01), BMI (AOR = 3.47, CI:1.44,8.32), waist-to-hip ratio (WHR) (AOR = 5.07, CI:2.15,11.98), and metabolic syndrome.

Conclusion

The prevalence of metabolic syndrome among patients with BPH is notably high. The authors recommend the need for early assessment of risk factors and timely intervention to prevent potential complications.